• / Free eNewsletters & Magazine
  • / My Account


  1. All
  2. Morningstar Articles
  3. Investing
  1. Greece’s Darkest Hour Before Its Dawn

    Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...

  2. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

    While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.

  3. Research Roundup: Foreign Diversification, Social Comparisons and Consumer Identity

    Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...

  4. A Deeper Look at the Applied Materials-Tokyo Electron Merger

    The combination makes plenty of sense and should better position the firm for the future.

  5. Credit Outlook: Sector Updates and Top Bond Picks

    Get our sector-by-sector take on the bond markets, plus our five best bond ideas.

Upcoming Events

©2014 Morningstar Advisor. All right reserved.